MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Vaccine Development & Manufacturing
Vaxxas
Organization & Developments: Vaxxas
Parents
Vaxxas
Children
* The HD-MAP also has the benefit of potentially requiring less training to administer and even allow for self-administration.
*The patch vaccine is expected to be a more stable alternative to needle and syringe vaccination due to its improved thermostability.
*Unlike traditional vaccines, HD-MAP does not require cold-chain distribution and storage, making it more cost-effective and easier to transport and store—both significant barriers to vaccine accessibility in lower- and middle-income countries.
2019: Nanopatch for Effective, Pain-Free Vaccine Delivery: Interview with David Hoey, CEO of Vaxxas_www.medgadget.com
2021: COVID-19 Vaccine Patch Does Not Require Cold Chain Transport
Jumps
Finance & Acquisition: Vaxxas
Key People: Vaxxas